Skip to main content

November 2013 - FRMC

11/21/2013
Kerri Fitzgerald
Male hypogonadism is associated with a number of chronic conditions, including decreased bone and muscle mass, sexual dysfunction, hypertension, hyperlipidemia, diabetes, back and neck pain, and psychiatric disorders. 
Male hypogonadism is associated with a number of chronic conditions, including decreased bone and muscle mass, sexual dysfunction, hypertension, hyperlipidemia, diabetes, back and neck pain, and psychiatric disorders. 
Male hypogonadism is associated...
11/21/2013
First Report Managed Care
News
11/21/2013
Kerri Fitzgerald
Allergen immunotherapy practice guidelines recommend specific immunotherapy for allergic rhinitis patients who remain symptomatic.
Allergen immunotherapy practice guidelines recommend specific immunotherapy for allergic rhinitis patients who remain symptomatic.
Allergen immunotherapy practice...
11/21/2013
First Report Managed Care
News
11/21/2013
Kerri Fitzgerald
Allergen immunotherapy practice guidelines recommend specific immunotherapy for allergic rhinitis patients who remain symptomatic.
Allergen immunotherapy practice guidelines recommend specific immunotherapy for allergic rhinitis patients who remain symptomatic.
Allergen immunotherapy practice...
11/21/2013
First Report Managed Care
11/21/2013
Kerri Fitzgerald
A study of biologic therapies for rheumatoid arthritis examined the impact on several characteristics among patients prescribed adalimumab, etanercept, or golimumab.
A study of biologic therapies for rheumatoid arthritis examined the impact on several characteristics among patients prescribed adalimumab, etanercept, or golimumab.
A study of biologic therapies...
11/21/2013
First Report Managed Care
Conference Insider
11/21/2013
Tim Casey
San Antonio—For more than 50 years, warfarin was the only anticoagulant that patients could use. In the past 3 years, though, the FDA has approved 3 more oral anticoagulants: dabigatran etexilate, rivaroxaban, and apixaban. Angela Allerman,...
San Antonio—For more than 50 years, warfarin was the only anticoagulant that patients could use. In the past 3 years, though, the FDA has approved 3 more oral anticoagulants: dabigatran etexilate, rivaroxaban, and apixaban. Angela Allerman,...
San Antonio—For more than 50...
11/21/2013
First Report Managed Care
Conference Insider
11/21/2013
Jill Sederstorm
San Antonio—For the Department of Defense (DOD), formulary decisions are made after a complex process that includes reviews of clinical effectiveness, cost effectiveness and manufacturer bids. Representatives from the DOD recently shared the...
San Antonio—For the Department of Defense (DOD), formulary decisions are made after a complex process that includes reviews of clinical effectiveness, cost effectiveness and manufacturer bids. Representatives from the DOD recently shared the...
San Antonio—For the Department...
11/21/2013
First Report Managed Care
11/21/2013
Tim Casey
More than 1.7 billion people have musculoskeletal conditions, making the diseases the second largest cause of disability, with the fourth largest impact on overall health in the world. 
More than 1.7 billion people have musculoskeletal conditions, making the diseases the second largest cause of disability, with the fourth largest impact on overall health in the world. 
More than 1.7 billion people...
11/21/2013
First Report Managed Care
11/21/2013
Kerri Fitzgerald
San Antonio—Diabetes accounted for $245 billion in total economic burden in 2012, a 41% increase from 2007. In addition to the disease, compounding factors such as glycosylated hemoglobin (A1C), body weight, and blood pressure (BP) are...
San Antonio—Diabetes accounted for $245 billion in total economic burden in 2012, a 41% increase from 2007. In addition to the disease, compounding factors such as glycosylated hemoglobin (A1C), body weight, and blood pressure (BP) are...
San Antonio—Diabetes accounted...
11/21/2013
First Report Managed Care
Conference Insider
11/21/2013
Tim Casey
San Antonio—Beginning in 2014, as mandated by the Patient Protection and Affordable Care Act (ACA), insurance companies are required to include 10 categories of services known as essential health benefits for all health plans. See Table. The...
San Antonio—Beginning in 2014, as mandated by the Patient Protection and Affordable Care Act (ACA), insurance companies are required to include 10 categories of services known as essential health benefits for all health plans. See Table. The...
San Antonio—Beginning in 2014,...
11/21/2013
First Report Managed Care
11/21/2013
Kevin L. Carter
The treatment of cancer is evolving from a largely reactive, empirical approach to a proactive one in which genomic information is used to improve diagnostic accuracy, guide therapeutic choices, and improve patient outcomes. 
The treatment of cancer is evolving from a largely reactive, empirical approach to a proactive one in which genomic information is used to improve diagnostic accuracy, guide therapeutic choices, and improve patient outcomes. 
The treatment of cancer is...
11/21/2013
First Report Managed Care
Conference Insider
11/21/2013
Eileen Koutnik-Fotopoulos
San Antonio—A range of issues at the federal and state level are affecting managed care pharmacy. Sean Karbowicz, PharmD, director, clinical evaluation and policy at RegenceRx, provided an update on some of the most significant legislative...
San Antonio—A range of issues at the federal and state level are affecting managed care pharmacy. Sean Karbowicz, PharmD, director, clinical evaluation and policy at RegenceRx, provided an update on some of the most significant legislative...
San Antonio—A range of issues at...
11/21/2013
First Report Managed Care
Conference Insider
11/21/2013
Tim Casey
San Antonio—Since the introduction of the Patient Protection and Affordable Care Act in March 2010, the healthcare industry has placed more of an emphasis on collaboration among providers. Pharmacists could also help physicians with concepts...
San Antonio—Since the introduction of the Patient Protection and Affordable Care Act in March 2010, the healthcare industry has placed more of an emphasis on collaboration among providers. Pharmacists could also help physicians with concepts...
San Antonio—Since the...
11/21/2013
First Report Managed Care
Conference Insider
11/21/2013
Kerri Fitzgerald
San Antonio—Atrial fibrillation (AF) is the most common form of cardiac arrhythmia, affecting between 2.7 million to 6 million US individuals. The prevalence of AF increases with age, affecting almost 10% of the population aged ≥80 years. In...
San Antonio—Atrial fibrillation (AF) is the most common form of cardiac arrhythmia, affecting between 2.7 million to 6 million US individuals. The prevalence of AF increases with age, affecting almost 10% of the population aged ≥80 years. In...
San Antonio—Atrial fibrillation...
11/21/2013
First Report Managed Care
Conference Insider
11/21/2013
Mary Mihalovic
San Antonio—Employers and managed care organizations alike are seeking ways to support the appropriate use of specialty pharmacy drugs; manage their utilization and cost; optimize site of service; and increase provider, client, and member...
San Antonio—Employers and managed care organizations alike are seeking ways to support the appropriate use of specialty pharmacy drugs; manage their utilization and cost; optimize site of service; and increase provider, client, and member...
San Antonio—Employers and...
11/21/2013
First Report Managed Care
Conference Insider
11/21/2013
Tim Casey
San Antonio—In May 2011, the FDA approved 2 direct acting antiviral oral medications that substantially improved sustained virologic response (SVR) in patients with genotype 1 hepatitis C: boceprevir and telaprevir. Still, these agents have...
San Antonio—In May 2011, the FDA approved 2 direct acting antiviral oral medications that substantially improved sustained virologic response (SVR) in patients with genotype 1 hepatitis C: boceprevir and telaprevir. Still, these agents have...
San Antonio—In May 2011, the FDA...
11/21/2013
First Report Managed Care
Conference Insider
11/21/2013
Jill Sederstorm
San Antonio—Specialty drugs may be used by a small percentage of the population, but they represent about 60% of drug approvals and continue to gain momentum in the pharmaceutical industry. An AMCP meeting session, led by Aimee Tharaldson,...
San Antonio—Specialty drugs may be used by a small percentage of the population, but they represent about 60% of drug approvals and continue to gain momentum in the pharmaceutical industry. An AMCP meeting session, led by Aimee Tharaldson,...
San Antonio—Specialty drugs may...
11/21/2013
First Report Managed Care
Conference Insider
11/20/2013
Mary Beth Nierengarten
San Antonio—Since 2010, the number of Accountable Care Organizations (ACOs) has grown in the United States, with many states now moving toward adopting this new model of healthcare delivery. Currently, most of the ACOs involve public programs...
San Antonio—Since 2010, the number of Accountable Care Organizations (ACOs) has grown in the United States, with many states now moving toward adopting this new model of healthcare delivery. Currently, most of the ACOs involve public programs...
San Antonio—Since 2010, the...
11/20/2013
First Report Managed Care
Conference Insider
11/20/2013
Kevin L. Carter
San Antonio—With more patented drugs reaching the patent cliff—the expiration of a patented drug that allows for the production of generics to compete—this will affect therapies and is expected to account for $74 billion in sales between 2013...
San Antonio—With more patented drugs reaching the patent cliff—the expiration of a patented drug that allows for the production of generics to compete—this will affect therapies and is expected to account for $74 billion in sales between 2013...
San Antonio—With more patented...
11/20/2013
First Report Managed Care
Conference Insider
11/20/2013
Tim Casey
San Antonio—The increasing role of biologics in treating diseases has benefited patients, but it has also led to rising costs. When assessing medications to prescribe, healthcare professionals need to evaluate their safety and effectiveness...
San Antonio—The increasing role of biologics in treating diseases has benefited patients, but it has also led to rising costs. When assessing medications to prescribe, healthcare professionals need to evaluate their safety and effectiveness...
San Antonio—The increasing role...
11/20/2013
First Report Managed Care
Conference Insider
11/20/2013
Eileen Koutnik-Fotopoulos
San Antonio—Specialty pharmacy is transforming from a drug distribution model to an integrated system that coordinates many aspects of patient care, enabling health plans to manage populations across all benefits and distribution channels. In...
San Antonio—Specialty pharmacy is transforming from a drug distribution model to an integrated system that coordinates many aspects of patient care, enabling health plans to manage populations across all benefits and distribution channels. In...
San Antonio—Specialty pharmacy...
11/20/2013
First Report Managed Care
Conference Insider
11/20/2013
Mary Beth Nierengarten
San Antonio—To better manage specialty pharmacy costs, managed care plans can look at a number of areas that drive up costs, such as copay coupon programs, as well as ways to reduce medical and pharmacy costs for high-cost diseases, such as...
San Antonio—To better manage specialty pharmacy costs, managed care plans can look at a number of areas that drive up costs, such as copay coupon programs, as well as ways to reduce medical and pharmacy costs for high-cost diseases, such as...
San Antonio—To better manage...
11/20/2013
First Report Managed Care
Conference Insider
11/20/2013
Mary Mihalovic
San Antonio—As of 2009, there were 9.2 million dual eligible beneficiaries in the United States. This population is among the sickest and costliest, accounting for a disproportionate share of federal and state spending, according to Mary...
San Antonio—As of 2009, there were 9.2 million dual eligible beneficiaries in the United States. This population is among the sickest and costliest, accounting for a disproportionate share of federal and state spending, according to Mary...
San Antonio—As of 2009, there...
11/20/2013
First Report Managed Care
Conference Insider
11/20/2013
Eileen Koutnik-Fotopoulos
San Antonio—Medicare Part D medication therapy management (MTM) programs are required to include both comprehensive medication reviews (CMRs) and targeted medication reviews (TMRs). CMRs are particularly important to plan sponsors because...
San Antonio—Medicare Part D medication therapy management (MTM) programs are required to include both comprehensive medication reviews (CMRs) and targeted medication reviews (TMRs). CMRs are particularly important to plan sponsors because...
San Antonio—Medicare Part D...
11/20/2013
First Report Managed Care
Conference Insider
11/20/2013
Tim Casey
San Antonio—Until recently, patients with multiple sclerosis (MS) received treatment via subcutaneous or intramuscular injections or intravenous infusions. In the past 3 years, however, the FDA has approved 3 oral medications to treat the...
San Antonio—Until recently, patients with multiple sclerosis (MS) received treatment via subcutaneous or intramuscular injections or intravenous infusions. In the past 3 years, however, the FDA has approved 3 oral medications to treat the...
San Antonio—Until recently,...
11/20/2013
First Report Managed Care
11/20/2013
Eileen Koutnik-Fotopoulos
The Institute of Medicine estimates that chronic pain affects about 100 million American adults—more than the total affected by heart disease, cancer, and diabetes combined.
The Institute of Medicine estimates that chronic pain affects about 100 million American adults—more than the total affected by heart disease, cancer, and diabetes combined.
The Institute of Medicine...
11/20/2013
First Report Managed Care
Conference Insider
11/20/2013
Eileen Koutnik-Fotopoulos
San Antonio—Specialty pharmaceuticals is the fastest growing segment of the pharmaceutical market in the United States. Industry projections have the growth rate at 20% per year. The care and delivery of specialty pharmaceuticals over the...
San Antonio—Specialty pharmaceuticals is the fastest growing segment of the pharmaceutical market in the United States. Industry projections have the growth rate at 20% per year. The care and delivery of specialty pharmaceuticals over the...
San Antonio—Specialty...
11/20/2013
First Report Managed Care
Conference Insider
11/20/2013
Tim Casey
San Antonio—With rising drug prices and an increase in the diagnosis of chronic conditions, patients must take their medications to improve their health and keep long-term healthcare costs down. Healthcare professionals have attempted...
San Antonio—With rising drug prices and an increase in the diagnosis of chronic conditions, patients must take their medications to improve their health and keep long-term healthcare costs down. Healthcare professionals have attempted...
San Antonio—With rising drug...
11/20/2013
First Report Managed Care
Conference Insider
11/20/2013
Tim Casey
San Antonio—For the first time in at least 60 years, prescription drug sales declined in 2012, falling 0.8% as several blockbuster drugs lost their patents, more people chose to use generics, and weak economic conditions led to a wider...
San Antonio—For the first time in at least 60 years, prescription drug sales declined in 2012, falling 0.8% as several blockbuster drugs lost their patents, more people chose to use generics, and weak economic conditions led to a wider...
San Antonio—For the first time...
11/20/2013
First Report Managed Care